iSpecimen (ISPC) Short-term Investments (2023 - 2024)

iSpecimen (ISPC) recorded quarterly Short-term Investments of $466493.0 in Q1 2024, down 82.48% quarter-over-quarter from $2.7 million in Q4 2023, and down 93.57% on a YoY basis from $7.3 million in Q2 2023.

iSpecimen (ISPC) Short-term Investments (2023 - 2024) Analysis & Trends

iSpecimen's Short-term Investments history runs 2 years deep, the most recent figure standing at $466493.0 for Q1 2024.

  • In Q1 2024, Short-term Investments fell 93.57% year-over-year to $466493.0; the TTM figure through Mar 2024 stood at $466493.0 (down 93.57% YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
  • Short-term Investments was $466493.0 for Q1 2024 at iSpecimen, down from $2.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $7.3 million in Q1 2023 to a low of $466493.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 iSpecimen 1.02 Mn -1.79 Mn -1.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 466,493.00
Dec 31, 2023 2.66 Mn
Sep 30, 2023 2.94 Mn
Jun 30, 2023 6.21 Mn
Mar 31, 2023 7.26 Mn